åêðáéäåõóçó γ.ν.α.
åêðáéäåõóçó γ.ν.α.
åêðáéäåõóçó γ.ν.α.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
426 Θεραπευτικά διλήμματα στις σπειραματονεφρίτιδες νεότερα δεδομένα και προτάσεις<br />
idiopathic childhood nephrosis: overdiagnosed and undertreated.<br />
Nephrol Dial Transplant. 2007;22(8):2183-93<br />
23. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent<br />
focal segmental glomerulosclerosis proteinuria<br />
after rituximab treatment. N Engl J Med. 2006;<br />
4;354(18):1961-3<br />
24. Segarra A, Amoedo ML, Martinez Garcia JM, et al. Efficacy<br />
and safety of ‘rescue therapy’ with mycophenolate mofetil<br />
in resistant primary glomerulonephritis--a multicenter<br />
study. Nephrol Dial Transplant. 2007;22(5):1351-60<br />
25. Thomas DB, Franceschini N, Hogan SL, et al. Clinical and<br />
pathologic characteristics of focal segmental glomerulosclerosis<br />
pathologic variants. Kidney Int. 2006;69(5):920-6<br />
26. Cattran DC: Idiopathic membranous glomerulonephritis.<br />
Kidney Int 2001; 59: 1983–1994<br />
27. Cattran D: Management of membranous nephropathy:<br />
When and what for treatment. J Am Soc Nephrol 2005;<br />
16: 1188– 1194<br />
28. Glassock RJ: The treatment of idiopathic membranous<br />
nephropathy: A dilemma or a conundrum Am J Kidney<br />
Dis 2004; 44: 562–566<br />
29. Alexopoulos E, Papagianni A, Tsamelashvili M, et al.<br />
Induction and long-term treatment with cyclosporine in<br />
membranous nephropathy with the nephritic syndrome.<br />
Nephrol Dial Transplant 2006; 21: 3127–3132<br />
30. Praga M, Barrio V, Juarez GF, et al. Tacrolimus monotherapy<br />
in membranous nephropathy: A randomized<br />
controlled trial. Kidney Int 2007; 71: 924–930<br />
31. Ponticelli C, Passerini P, Salvadori M, et al. A randomized<br />
pilot trial comparing methylprednisolone plus a cytotoxic<br />
agent versus synthetic adrenocorticotropic hormone in<br />
idiopathic membranous nephropathy. Am J Kidney Dis<br />
2006; 47: 233–240<br />
32. Fervenza FC, Sethi S, Specks U. Idiopathic membranous<br />
nephropathy: diagnosis and treatment. Clin J Am Soc<br />
Nephrol. 2008;3(3):905-19<br />
33. Fervenza FC, Cosio FG, Erickson SB et al. Rituximab<br />
treatment of idiopathic membranous nephropathy.<br />
Kidney Int. 2008 Jan;73(1):117-25<br />
34. Ruggenenti P, Chiurchiu C, Brusegan V et al. Rituximab<br />
in idiopathic membranous nephropathy: a oneyear<br />
prospective study. J Am Soc Nephrol 2003; 14:<br />
1851–1857<br />
35. Cattran DC, Appel GB, Hebert LA, et al. Cyclosporine in<br />
patients with steroid-resistant membranous nephropathy:<br />
a randomized trial. Kidney Int 2001; 59: 1484–1490<br />
xxxxxxxxxxx<br />
xxxxxx
Change language